CD8A and diffuse large B-cell lymphoma: When response to treatment was analyzed, R/R DLBCL patients with CR had a significant higher level of basal CD8+ NKs than patients with PD (p=0.0006) (Figure 2A), whereas there were no differences in treatment response in CD8- NK subpopulation (Figure 2A).